Bio-Techne

Traded on the St. Petersburg Stock Exchange
Bio-Techne is an American biotechnology holding company that evelops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets. Bio-Techne was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Bio-Techne stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Bio-Techne balance sheet

Report period2019 2020 2021 20222023 Q2 24
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Bio-Techne cash flows

Report period2019 2020 2021 20222023 Q2 24 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Bio-Techne multipliers

Report period2019 2020 2021 20222023 Q2 24 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Bio-Techne profitability

Report period2019 2020 2021 20222023 Q2 24 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Bio-Techne assets
Bio-Techne cash flows
Bio-Techne dividends
0.46%

Bio-Techne dividend policy

The company provides dividend on a quarterly basis

Bio-Techne shares

TickerNameTypeNominal valueISINPrice
TECH:USBio-TechneCommon share-US09073M1045$71.5
Bio-Techne news
04.05.2022
The Bio-Techne Board of Directors announced a quarterly dividend of $0.32 per share. The last day to buy securities to receive the dividend is May 12, 2022. The annual dividend yield may reach 0.29%.
Source: {source} pictogram investors.bio-techne.com
Pictogram next
04.05.2022
Bio-Techne's GAAP net income for 9 months of fiscal year 2022 was $201.184 million, up 61% from $124.941 million in the prior year. Revenue increased 21.6% to $817.371 million from $672.004 million a year earlier.
Source: {source} pictogram investors.bio-techne.com
Pictogram next
01.02.2022
Bio-Techne's board of directors has declared a quarterly dividend of $0.32 per share. The last day to purchase securities to receive the dividend is Feb. 9, 2022. The annual dividend yield could be 0.3%.
Source: {source} pictogram investors.bio-techne.com
Pictogram next
01.02.2022
Bio-Techne's GAAP net income for 6 months 2022 fiscal year was $141.04 million, up 77.3% from $79.538 million in the prior year. Revenue increased 23% to $526.995 million from $428.452 million a year earlier.
Source: {source} pictogram investors.bio-techne.com
Pictogram next
All Bio-Techne news
General information
Company nameBio-Techne
Tags#biotechnology, #s&p500 index
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address614 McKinley Place NE Minneapolis, MN 55413 United States
Mailing address614 McKinley Place NE Minneapolis, MN 55413 United States
Websiteinvestors.bio-techne.com
Information disclosurewww.sec.gov